Intelligence · Clinical pipeline
Autoimmune & immunology · Phase III
Autoimmune & immunology programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Autoimmune & immunology Phase III programs: NovaPharmaNews indexes 368 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 39 programs
- Janssen-Cilag International N.V 26 programs
- Anaxis Pharma 20 programs
- AbbVie 18 programs
- Novartis India 17 programs
- AbbVie Deutschland GmbH 13 programs
- HOFFMANN-LA ROCHE 11 programs
- Eli Lilly and 9 programs
- Chinese Academy of 8 programs
- Bristol-Myers Squibb Australia 7 programs
- PARItec 7 programs
- Pacira Ireland 7 programs
Pipeline programs
-
CVAY736F12302
Novartis Pharmaceuticals
Systemic Lupus Erythematosus
1 trial -
CVAY736K12301
Novartis Pharmaceuticals
Lupus nephritis
1 trial -
CVAY736K12301E1
Novartis Pharmaceuticals
Lupus nephritis
1 trial -
CVAY736O12301
Novartis Pharmaceuticals
warm autoimmune haemolytic anaemia (wAIHA)
1 trial -
Cardioblate® Surgical Ablation System
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatic Valve Disease
1 trial -
Cenerimod
Viatris Pharmaceuticals Co.,
Lupus Erythematosus, Systemic
2 trials -
Cenerimod 4 mg
Viatris Pharmaceuticals Co.,
Systemic lupus erythematosus
1 trial -
Cenerimod 4 mg, Cenerimod matching placebo
Viatris Pharmaceuticals Co.,
Moderate to severe systemic lupus erythematosus
1 trial -
Cenerimod matching placebo, Cenerimod 4 mg
Viatris Pharmaceuticals Co.,
Moderate to severe systemic lupus erythematosus
1 trial -
Cx601
Takeda
Crohn's Disease
3 trials -
D346BC00001
AstraZeneca AB
Cutaneous Lupus Erythematosus
1 trial -
Darvadstrocel
Takeda
Complex Perianal Fistulas in Adult Participants With Crohn's Disease
1 trial -
Delayed and extended release mesalazine
Takeda
Colitis, Ulcerative
1 trial -
Dexamethasone
Quince Therapeutics
Crohn's Disease
1 trial -
Diclofenac Sodium Topical Gel, 1%
Amneal Pharma Europe Ltd
Osteoarthritis
1 trial -
Donepezil
Universal Integrated
Osteoarthritis
1 trial -
Double-blind 200 mg imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Duloxetine
Pacira Ireland Limited
Knee Osteoarthritis
1 trial -
Duvakitug
Teva Pharma GmbH
Ulcerative Colitis
2 trials -
Duvakitug
Teva Pharma GmbH
Crohn's Disease
2 trials -
EFC17360 - LUMINA 3
Sanofi-aventis Healthcare Pty Ltd
Autoimmune haemolytic anaemia
1 trial -
EFGARTIGIMOD ALFA, JNJ-80202135
Janssen-Cilag International N.V.
generalized myasthenia gravis
1 trial -
Enbrel solution for injection in pre-filled s... for Chronic Plaque Psoriasis
Janssen-Cilag International N.V.
Chronic Plaque Psoriasis
1 trial -
Etanercept
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Etanercept
Coherus Oncology
Plaque Psoriasis
1 trial -
Etanercept
Coherus Oncology
Rheumatoid Arthritis
1 trial -
Etrasimod Arginine Blue
Lacuna Pharma Pty Ltd
Ulcerative Colitis
1 trial -
FX006
Pacira Ireland Limited
Osteoarthritis of the Knee
2 trials -
FX006
Pacira Ireland Limited
Osteoarthritis, Hip
1 trial -
FX006 32 mg
Pacira Ireland Limited
Osteoarthritis of the Knee
4 trials -
FX006 32 mg
Pacira Ireland Limited
Osteoarthritis, Knee
1 trial -
Fasinumab
Regeneron UK Limited
Osteoarthritis, Knee
4 trials -
Fasinumab
Regeneron UK Limited
Osteoarthritis of the Knee or Hip
1 trial -
Filgotinib
Alfasigma S.p.A.
Axial Spondyloarthritis
1 trial -
Filgotinib
Lakefront Biotherapeutics NV
Psoriatic Arthritis
4 trials -
Filgotinib
Lakefront Biotherapeutics NV
Crohn's Disease
2 trials -
Filgotinib
Lakefront Biotherapeutics NV
Ulcerative Colitis
2 trials -
Fostamatinib disodium
RIGEL PHARMACEUTICALS INC
Warm Antibody Autoimmune Hemolytic Anemia
2 trials -
GLPG0634-CL-329
Alfasigma S.p.A.
Polyarticular-course juvenile idiopathic arthritis
1 trial -
GLPG0634-CL-331
Alfasigma S.p.A.
Ulcerative colitis
1 trial -
GLPG0634-CL-333
Alfasigma S.p.A.
Juvenile idiopathic arthritis
1 trial -
GS-US-417-0304
Alfasigma S.p.A.
Rheumatoid arthritis
1 trial -
GS-US-418-3899
Alfasigma S.p.A.
Ulcerative Colitis (UC)
1 trial -
GSK1605786A
GlaxoSmithKline
Crohn's Disease
2 trials -
GSK3196165 (Otilimab)
GlaxoSmithKline
Arthritis, Rheumatoid
1 trial -
GW406381
GlaxoSmithKline
Osteoarthritis, Knee
1 trial -
Gefurulimab
Alexion Europe SAS
Generalized Myasthenia Gravis with autoantibodies against acetylcholine receptor (AChR)
1 trial -
Golimumab 1 mg per kg
Janssen Cilag International NV
Colitis, Ulcerative
1 trial
Frequently asked questions
How many autoimmune & immunology Phase III programs exist?
368 programs match both the therapeutic area and stage filters in our published index.